G

GenVault

Room-temperature biosample storage and management

Overview

GenVault stores and manages biological samples and genetic material at room temperature, offering a cost- and space-efficient alternative to traditional freezer storage. Its product lineup includes chemically treated papers and plates for collecting and storing samples, plus automated systems for handling, archiving, and retrieving them. The core idea is to stabilize DNA and RNA without refrigeration so samples stay viable over the long term, even in power outages. This differentiates GenVault from competitors by combining ambient-temperature preservation with automated sample management, reducing energy use and freezer maintenance costs. The company aims to provide scalable, reliable biosample storage and management that supports longitudinal research, drug discovery, and clinical diagnostics while cutting environmental and financial costs.

Significant Headcount Growth

Work here?Claim your company

About GenVault

Simplify's Rating
Why GenVault is rated
B-
Rated B on Competitive Edge
Rated B on Growth Potential
Rated C on Differentiation

Industries

Robotics & AutomationIndustrial & ManufacturingBiotechnologyHealthcare

Company Size

11-50

Company Stage

Acquired

Total Funding

$85.6M

Headquarters

West Deptford Township, New Jersey

Founded

2001

Get referred to GenVault

See people who can refer or advise you

Simplify Jobs

Simplify's take

What believers are saying

  • July 2026 government lab move from Maryland to Arizona showcases national relocation capability.
  • November 2026 Diligent Pharma listed GenVault among top biobanking and sample-management providers.
  • October 15, 2026 Pennsylvania Biotechnology Center conference kept GenVault visible to regional buyers.

What critics are saying

  • Diligent Pharma's 2026 writeup says GenVault was founded in 2020, conflicting with legacy branding.
  • GenVault's blog admits vendor fragmentation and chain-of-custody gaps break CDMO and CGT programs.
  • Any freezer failure or transport error destroys irreplaceable samples, triggering lawsuits and customer churn.

What makes GenVault unique

  • West Deptford campus spans half a million square feet, combining storage and transport.
  • GenVault offers ambient-to-cryogenic custody, plus moving freezers across town or country.
  • Its 2026 content emphasizes chain-of-identity, cGMP compliance, and lab relocation expertise.

Help us improve and share your feedback! Did you find this helpful?

Funding

Total Funding

$85.6M

Meets

Industry Average

Funded Over

8 Rounds

Acquisition funding comparison data is currently unavailable. We're working to provide this information soon!
Acquisition Funding Comparison Coming Soon

Benefits

  • Health Insurance
  • Dental Insurance
  • Vision Insurance
  • Company Paid Short-Term Disability
  • Company Paid Long-Term Disability
  • Accident/Critical Illness/Hospital Insurance
  • Pet Insurance Options
  • PTO
  • 401K with Employer Match

Growth & Insights and Company News

6 month growth

9%

1 year growth

41%

2 year growth

41%
Google
Aug 9th, 2023
GenVault Biorepository Announces Executive Director Appointment

WEST DEPTFORD, N.J., August 09, 2023--( BUSINESS WIRE )-- GenVault, one of the nation's most secure, comprehensive commercial facilities for bioinventory storage and transport, announces the appointment of Andrew Lee as executive director.

Recently Posted Jobs

Sign up to get curated job recommendations

GenVault is Hiring for 1 Jobs on Simplify!

Find jobs on Simplify and start your career today

Don't see your dream role? Check out thousands of other roles on Simplify.Browse all jobs